Aestheticsrx Pharma Ltd (9012430) - Improvement action plan

The pharmacy does not have documented risk assessments for the medicines it provides. This includes for botulinum toxins, and weight loss medicines. And it cannot show it has considered the need to restrict the quantity and frequency of the medicines it supplies. The pharmacy does not have documented risk assessments to identify and mitigate risks of not having face to face consultations when necessary. It does not have a policy for carrying out checks to provide ongoing assurance that prescribers can legally prescribe. And it does not have a documented risk assessment when working with third-party companies to check the prescriptions they receive are appropriate and safe to supply to patients.

- Documented risk assessments for high-risk
medicines (botulinum toxins, weight loss
treatments).
- Documented risk assessments for
non-medical products such as skin boosters,
dermal fillers and polynucleotide.
- Implement quantity/frequency restrictions
per treatment protocol.
- Risk assessment protocol for face-to-face
consultations where clinically necessary..
- SOP and checklist to validate prescriber
registration and legal prescribing scope.
- Formal risk assessments for any future
third-party partnerships with governance agreements

The pharmacy cannot demonstrate it always delivers its services safely. It doesn't always have the information it needs for the pharmacist to adequately complete the clinical check. And it doesn't know if people's weights are independently verified. Checks to confirm prescriber's registration aren't made. And there are no records of interventions to show that doses and frequency of supplies are always appropriate. The pharmacy doesn't confirm face to face consultations are carried out when appropriate, even though prescribers and people's addresses are geographically widespread. And it doesn't ensure that all prescriptions are labelled with specific instructions to ensure people receive treatment as intended.

- Update patient questionnaire to require
recent weight with confirmation method
(self-reported, verified via video, or GP letter).
- System to cross-reference prescriber
registration monthly.
- Clinical review template requiring evidence
of dosage appropriateness, clinical need, and
consultation type (remote/video/in-person).
- All prescriptions will now include specific
labelling instructions per condition and
medicine.
- Audit log to record interventions and
dose/frequency justifications.
- All prescription requests will require
confirmation of a face to face (where
appropriate) being completed.